BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24130709)

  • 1. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
    Mowry EM; Carey RF; Blasco MR; Pelletier J; Duquette P; Villoslada P; Malikova I; Roger E; Kinkel RP; McDonald J; Bacchetti P; Waubant E
    PLoS One; 2013; 8(10):e75416. PubMed ID: 24130709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
    Mowry EM; Carey RF; Blasco MR; Pelletier J; Duquette P; Villoslada P; Malikova I; Roger E; Kinkel RP; McDonald J; Bacchetti P; Waubant E
    PLoS One; 2013; 8(10):e75565. PubMed ID: 24130718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of CD6, TNFRSF1A and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
    Park TJ; Kim HJ; Kim JH; Bae JS; Cheong HS; Park BL; Shin HD
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):519-30. PubMed ID: 22994200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALCAM and CD6--multiple sclerosis risk factors.
    Wagner M; Bilinska M; Pokryszko-Dragan A; Sobczynski M; Cyrul M; Kusnierczyk P; Jasek M
    J Neuroimmunol; 2014 Nov; 276(1-2):98-103. PubMed ID: 25216742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
    Swaminathan B; Matesanz F; Cavanillas ML; Alloza I; Otaegui D; Olascoaga J; Cénit MC; de las Heras V; Barcina MG; Arroyo R; Alcina A; Fernandez O; Antigüedad A; Urcelay E; Vandenbroeck K
    J Neuroimmunol; 2010 Jun; 223(1-2):100-3. PubMed ID: 20430450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
    De Jager PL; Jia X; Wang J; de Bakker PI; Ottoboni L; Aggarwal NT; Piccio L; Raychaudhuri S; Tran D; Aubin C; Briskin R; Romano S; ; Baranzini SE; McCauley JL; Pericak-Vance MA; Haines JL; Gibson RA; Naeglin Y; Uitdehaag B; Matthews PM; Kappos L; Polman C; McArdle WL; Strachan DP; Evans D; Cross AH; Daly MJ; Compston A; Sawcer SJ; Weiner HL; Hauser SL; Hafler DA; Oksenberg JR
    Nat Genet; 2009 Jul; 41(7):776-82. PubMed ID: 19525953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.
    International Multiple Sclerosis Genetics Consortium
    PLoS One; 2011 Apr; 6(4):e18813. PubMed ID: 21552549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.
    Kofler DM; Farkas A; von Bergwelt-Baildon M; Hafler DA
    Curr Drug Targets; 2016; 17(6):651-65. PubMed ID: 26844569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.
    Wagner M; Wiśniewski A; Bilińska M; Pokryszko-Dragan A; Nowak I; Kuśnierczyk P; Jasek M
    J Neuroimmunol; 2013 May; 258(1-2):71-6. PubMed ID: 23507476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
    Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
    Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.
    Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M
    Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.
    Patsopoulos NA; Barcellos LF; Hintzen RQ; Schaefer C; van Duijn CM; Noble JA; Raj T; ; ; Gourraud PA; Stranger BE; Oksenberg J; Olsson T; Taylor BV; Sawcer S; Hafler DA; Carrington M; De Jager PL; de Bakker PI
    PLoS Genet; 2013 Nov; 9(11):e1003926. PubMed ID: 24278027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association analysis of cytokine receptors' genes polymorphisms with clinical features of multiple sclerosis].
    Kulakova OG; Bashinskaya VV; Tsareva EY; Boyko AN; Favorova OO; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10. Vyp. 2):10-15. PubMed ID: 28139605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.
    Graetz C; Gröger A; Luessi F; Salmen A; Zöller D; Schultz J; Siller N; Fleischer V; Bellenberg B; Berthele A; Biberacher V; Havla J; Hecker M; Hohlfeld R; Infante-Duarte C; Kirschke JS; Kümpfel T; Linker R; Paul F; Pfeuffer S; Sämann P; Toenges G; Weber F; Zettl UK; Jahn-Eimermacher A; Antony G; Groppa S; Wiendl H; Hemmer B; Mühlau M; Lukas C; Gold R; Lill CM; Zipp F
    Mult Scler; 2019 Apr; 25(5):661-668. PubMed ID: 29532745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
    Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T
    Mult Scler; 2013 Jun; 19(7):863-70. PubMed ID: 23175382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
    Ďurmanová V; Shawkatová I; Javor J; Párnická Z; Čopíková-Cundráková D; Turčáni P; Lisá I; Gajdošechová B; Buc M; Bucová M
    Folia Biol (Praha); 2015; 61(1):8-13. PubMed ID: 25958306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.